BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22264047)

  • 1. Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development.
    Eade CR; Wood MP; Cole AM
    Curr HIV Res; 2012 Jan; 10(1):61-72. PubMed ID: 22264047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Past, present, and future of entry inhibitors as HIV microbicides.
    Gibson RM; Arts EJ
    Curr HIV Res; 2012 Jan; 10(1):19-26. PubMed ID: 22264042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models for microbicide studies.
    Veazey RS; Shattock RJ; Klasse PJ; Moore JP
    Curr HIV Res; 2012 Jan; 10(1):79-87. PubMed ID: 22264049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of antiretroviral drugs as microbicides.
    Balzarini J; Schols D
    Curr HIV Res; 2012 Jan; 10(1):53-60. PubMed ID: 22264046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo models of HIV sexual transmission and microbicide development.
    Ariƫn KK; Kyongo JK; Vanham G
    Curr HIV Res; 2012 Jan; 10(1):73-8. PubMed ID: 22264048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbicides: a new hope for HIV prevention.
    ; Gupta SK
    Indian J Med Res; 2011 Dec; 134(6):939-49. PubMed ID: 22310826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal microbicides and the prevention of HIV transmission.
    Cutler B; Justman J
    Lancet Infect Dis; 2008 Nov; 8(11):685-97. PubMed ID: 18992405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal microbicides and their delivery platforms.
    D'Cruz OJ; Uckun FM
    Expert Opin Drug Deliv; 2014 May; 11(5):723-40. PubMed ID: 24506783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission.
    Klasse PJ; Shattock R; Moore JP
    Annu Rev Med; 2008; 59():455-71. PubMed ID: 17892435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal microbicides.
    O'Brien RF
    Adolesc Med Clin; 2006 Oct; 17(3):673-85; abstract xi. PubMed ID: 17030285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Caulobacter crescentus Microbicide Protects from Vaginal Infection with HIV-1
    Farr Zuend C; Nomellini JF; Smit J; Horwitz MS
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice.
    Neff CP; Kurisu T; Ndolo T; Fox K; Akkina R
    PLoS One; 2011; 6(6):e20209. PubMed ID: 21673796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential use of protease inhibitors as vaginal and colorectal microbicides.
    Herrera C; Shattock RJ
    Curr HIV Res; 2012 Jan; 10(1):42-52. PubMed ID: 22264045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-specific microbicide product development: then and now.
    Romano JW; Robbiani M; Doncel GF; Moench T
    Curr HIV Res; 2012 Jan; 10(1):9-18. PubMed ID: 22264041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twice-daily application of HIV microbicides alter the vaginal microbiota.
    Ravel J; Gajer P; Fu L; Mauck CK; Koenig SS; Sakamoto J; Motsinger-Reif AA; Doncel GF; Zeichner SL
    mBio; 2012 Dec; 3(6):. PubMed ID: 23249810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Antiretroviral Microbicides for HIV Prevention.
    Scott Y; Dezzutti CS
    AIDS Rev; 2016; 18(3):145-150. PubMed ID: 27438574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of HIV prevention: prospects for an effective anti-HIV microbicide.
    Nuttall J; Romano J; Douville K; Galbreath C; Nel A; Heyward W; Mitchnick M; Walker S; Rosenberg Z
    Infect Dis Clin North Am; 2007 Mar; 21(1):219-39, x. PubMed ID: 17502237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.
    Herold BC; Mesquita PM; Madan RP; Keller MJ
    Am J Reprod Immunol; 2011 Mar; 65(3):325-33. PubMed ID: 21143689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethical issues in microbicide clinical trials for HIV prevention.
    Gangestad AK; Salata RA
    Curr HIV Res; 2012 Jan; 10(1):105-12. PubMed ID: 22264052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.